MetLife Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

MetLife Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,701	Closed	-$781K	–	2944
2024 Q1	$781K	Buy	19,701 +2,883	+17%	+$85.1K	0.01%	1438
2023 Q4	$321K	Hold	16,818	–	–	﹤0.01%	1953
2023 Q3	$193K	Hold	16,818	–	–	﹤0.01%	2234
2023 Q2	$173K	Buy	16,818 +4,790	+40%	+$43.2K	﹤0.01%	2370
2023 Q1	$92.9K	Hold	12,028	–	–	﹤0.01%	2582
2022 Q4	$88.4K	Buy	+12,028	New	+$76.9K	﹤0.01%	2637

MetLife Investment Management's ALPN Position: Q2 2024 in Review

MetLife Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 19,701 shares — an estimated $781K sold.

MetLife Investment Management first reported a position in ALPN in Q4 2022 and held it in 6 quarters. The position peaked at $781K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

MetLife Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
MetLife Investment Management sold 19,701 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $781K.
MetLife Investment Management first reported a position in Alpine Immune Sciences Inc in Q4 2022 and held it in 6 quarters.
MetLife Investment Management's Alpine Immune Sciences Inc position peaked at $781K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.